Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Elastin is Responsible for Tissue Elasticity

Elastin is Responsible for Tissue Elasticity

Elastic fiber contains the protein elastin along with lesser amounts of other proteins and glycoproteins. The main property of elastin is that it will return to its original shape after being stretched or compressed. Elastic fibers are prominent in elastic tissues found in skin and the elastic ligaments of the vertebral column.
Ligaments and tendons are made of dense regular connective tissue, but in ligaments not all fibers are parallel. Dense regular elastic tissue contains elastin fibers and...

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Oral Drug Delivery Systems: Delayed-Release Systems

Oral Drug Delivery Systems: Delayed-Release Systems

Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Versatile Engineering Platform for the Fabrication of Prosthetic Venous Valves Using Electrospinning.

Advanced healthcare materials·2026

Same author

Elastic, load-bearing and autoclavable protein-based graft for coronary revascularization.

Frontiers in bioengineering and biotechnology·2026

Same author

Biohybrid microvascular interponates with integrated elastin-like recombinamers - validation of stability and biomimetic elasticity in human vessels.

Scientific reports·2025

Same author

Mineralizing Elastin-Like Protein Microgels.

Journal of biomedical materials research. Part A·2025

Same author

Small patients - Big needs: A material-based approach to develop miniaturised valves for congenital heart diseases.

Bioactive materials·2025

Same author

Biomimetic supramolecular protein matrix restores structure and properties of human dental enamel.

Nature communications·2025

Search research articles

Related Experiment Video

Updated: Mar 28, 2026

Efficient Purification of Elastin-Like Polypeptides (ELPs) from E. coli Using an Organic Solvent-based Extraction and Precipitation Method

Efficient Purification of Elastin-Like Polypeptides (ELPs) from E. coli Using an Organic Solvent-based Extraction and Precipitation Method

Published on: January 9, 2026

Elastin-like polypeptides in drug delivery.

José Carlos Rodríguez-Cabello¹, Francisco Javier Arias¹, Matilde Alonso Rodrigo¹

¹Bioforge, University of Valladolid, Valladolid, Spain; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain.

Advanced Drug Delivery Reviews

|December 26, 2015

Summary

This summary is machine-generated.

Recombinant elastin-like recombinamers (ELRs) offer advanced drug delivery with unique stimuli-responsive and self-assembling properties. Their recombinant nature enables complex designs for efficient drug loading and targeted delivery systems.

Keywords:

Chemotherapeutic agents Drug delivery Elastin-like recombinamers Macro-depots Nano-carriers Self-assembling Thermo-responsive materials

More Related Videos

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Published on: May 19, 2018

Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli

Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli

Published on: June 9, 2014

Related Experiment Videos

Last Updated: Mar 28, 2026

Efficient Purification of Elastin-Like Polypeptides (ELPs) from E. coli Using an Organic Solvent-based Extraction and Precipitation Method

Efficient Purification of Elastin-Like Polypeptides (ELPs) from E. coli Using an Organic Solvent-based Extraction and Precipitation Method

Published on: January 9, 2026

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Published on: May 19, 2018

Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli

Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli

Published on: June 9, 2014

Area of Science:

Biomaterials Science
Drug Delivery Systems
Protein Engineering

Background:

Elastin-like recombinamers (ELRs) are polymers initially explored for drug delivery.
Conventional polymeric carriers have limitations in functionality and efficiency.
ELRs possess unique properties like stimuli-responsiveness and self-assembly.

Purpose of the Study:

To review the application of ELRs in drug delivery.
To highlight the advantages of ELRs over conventional carriers.
To showcase the potential of recombinant technology in designing advanced drug delivery systems.

Main Methods:

Review of existing literature on ELR-based drug delivery systems.
Analysis of ELR properties, including stimuli-responsiveness and self-assembly.
Examination of how recombinant technology enhances ELR design and functionality.

Main Results:

ELRs provide unparalleled functionality and efficiency in drug delivery.
Stimuli-responsiveness and self-assembly of ELRs enable the creation of advanced systems.
Recombinant technology allows complex macromolecular design and incorporation of functional domains, leading to sophisticated interactions with drugs and biological targets.

Conclusions:

ELR-based drug delivery systems represent a significant advancement.
The recombinant nature of ELRs is key to their breakthrough properties.
ELRs can be engineered into diverse systems, from nanocarriers to macrodepots, for targeted therapeutic applications.